Good Outcomes After TAVR for Failed Surgical Bioprostheses Good Outcomes After TAVR for Failed Surgical Bioprostheses

Patients who undergo transcatheter aortic valve replacement (TAVR) for failed surgical bioprostheses have good 1-year outcomes with low mortality rates, according to results from the CoreValve US Expanded Use Study.Reuters Health Information
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Cardiology News Source Type: news